Lonza - PBMCs

Articles

Early-stage biotech: The wrong outsourcing strategy costs more than time

For early-stage biotech companies, innovation is just the beginning—the greater challenge lies in navigating the complex development path with limited time, resources, and visibility.

From Discovery to Delivery: The Rise of New Modalities

In the rapidly evolving landscape of pharmaceuticals and biotechnology, the emergence of multimodal drug discovery heralds a transformative era, where innovation and strategic foresight are paramount.

The New RNA World: Evolving RNA from Messenger to Versatile Therapeutic

RNA has evolved from a molecular messenger into a powerful and versatile therapeutic tool.

Ensuring compliance through collaboration: managing raw material changes in cell and gene therapy regulatory filings

Cell and gene therapy manufacturing depends on specialized raw materials, ranging from upstream reagents to downstream excipients, that are essential to product quality, consistency, and safety.

The Evolution of Antibody Drug Discovery: Unlocking Innovation with Bioinformatic and AIs

Since monoclonal antibodies (mAbs) were developed and received their first approval, they became indispensable as research tools and biotherapeutic agents.

The Innovation Imperative: Pioneering New Modalities for Therapeutic Leadership

In the rapidly evolving landscape of pharmaceuticals and biotechnology, the emergence of multimodal drug discovery heralds a transformative era for drug discovery, where innovation and strategic Foresight are paramount.

From early innovations to commercial triumphs: One viral vector partner for every stage of gene therapy development

Viral vector-based gene therapies hold promise for treating previously untreatable diseases like genetic disorders, rare cancers, and infectious diseases.

Outsourcing supply chain and buffer preparation activities

As the biopharmaceutical market evolves and continues a steep upward trajectory of growth, biopharmaceutical drug innovators increasingly rely on contract development and manufacturing organizations (CDMOs) to help them achieve their mission.